number of ozempic wegovy prescriptions q3 2024 semaglutide tirzepatide Weight loss drugs: expectations for Wegovy, Ozempic, Zepbound Weight-loss drugs such as Ozempic

Ozempic and Mounjaro are not FDA-approved to treat obesity or for weight loss

Often, compounded tirzepatide medication will be substantially less than the retail price of the name brand FDA-approved brand name drugs Mounjaro and Zepbound *

PlexusDx serves all 50 states with no membership fees, and HSA/FSA accounts are eligible for payment

In most insulin syringes, this dead space is minimal (0.5-2 units)

Tirzepatide Efficacy Data and Clinical Context Tirzepatide demonstrated superior weight loss outcomes compared to semaglutide in head-to-head trials, with patients on the highest doses achieving approximately 22% body weight reduction over 72 weeks

The transition timeline varies based on individual metabolism, your prior semaglutide dose, and dosing protocols